Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the waning work hours before the big holiday. Whether you’ve chosen to visit loved ones or observe in isolation, we’d advise you to keep your decision out of the paper of record. In the meantime, here are your requisite tidbits to get the day started. As always, if you hear something interesting out there, do let us know.
The European Union is planning a sweeping change in its rules governing generic drugs, Reuters reports, a move that could cut into the bottom lines of global pharmaceutical firms. The draft law, which could take effect in 2022, would crack down on firms that delay the approval of generics, limit patent protection for companies that don’t make their products available in all 27 member states, and aim to prevent drug shortages across the EU.
About the Author Reprints
